SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008461
Filing Date
2022-05-12
Accepted
2022-05-12 09:58:39
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20220331x10q.htm   iXBRL 10-Q 1003157
2 EX-31.1 fencf-20220331xex31d1.htm EX-31.1 13953
3 EX-31.2 fencf-20220331xex31d2.htm EX-31.2 18464
4 EX-32.1 fencf-20220331xex32d1.htm EX-32.1 9362
5 EX-99.1 fencf-20220331xex99d1.htm EX-99.1 128680
6 GRAPHIC fencf-20220331x10q002.jpg GRAPHIC 15349
7 GRAPHIC fencf-20220331xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001558370-22-008461.txt   4580445

Data Files

Seq Description Document Type Size
8 EX-101.SCH fencf-20220331.xsd EX-101.SCH 38490
9 EX-101.CAL fencf-20220331_cal.xml EX-101.CAL 30324
10 EX-101.DEF fencf-20220331_def.xml EX-101.DEF 172693
11 EX-101.LAB fencf-20220331_lab.xml EX-101.LAB 257835
12 EX-101.PRE fencf-20220331_pre.xml EX-101.PRE 250650
50 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20220331x10q_htm.xml XML 636729
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 22916163
SIC: 2836 Biological Products, (No Diagnostic Substances)